Inflammatix
1.6K
Volume
+11%
Growth
regular
About the Topic
A biotechnology company focused on developing a point-of-care instrument platform for diagnosing acute infections and sepsis. Inflammatix leverages the immune system to provide advanced immune response diagnostics, differentiating itself by offering rapid and accurate diagnostic solutions. The primary beneficiaries of Inflammatix's technology are healthcare providers and patients requiring swift and precise infection diagnosis.
Inflammatix was discovered on February 28th 2023 and it currently has a search volume of 1.6K with a growth of +11%.
Key Indicators
Growth
- Exploding
- Regular
- Peaked
Speed
- Exponential
- Constant
- Stationary
Seasonality
- High
- Medium
- Low
Volatility
- High
- Average
- Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Save this topic and build your own trend dashboard.
Available with Exploding Topics Pro, try it now.
1.1M+ trends in our growing database.